2-((4-(trifluoromethoxy)phenyl)amino)naphthalene-1,4-dione | 1537-95-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 2-((4-(trifluoromethoxy)phenyl)amino)naphthalene-1,4-dione
• 英文别名: 2-[4-(Trifluoromethoxy)anilino]naphthalene-1,4-dione
• CAS: 1537-95-7
• 化学式: C₁₇H₁₀F₃NO₃
• 分子量: 333.267
• InChiKey: KMNAQXWNBWBAOH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  24
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  2-((4-(trifluoromethoxy)phenyl)amino)naphthalene-1,4-dione 在 palladium diacetate 、 溶剂黄146 作用下， 以79 %的产率得到2-(trifluoromethoxy)-5H-benzo[b]carbazole-6,11-dione
  参考文献：
  名称：

  BENZOCARBAZOLE DERIVATIVES AS INHIBITORS OF DRP1

  摘要：

  The present application relates to compounds of Formula (I), Formula (II), and Formula (III) and to pharmaceutically acceptable salts and solvates of any of the foregoing, as well as pharmaceutical compositions and methods of using same to treat various diseases such as neurological and cardiac disorders.

  公开号：

  WO2023249965A1
• 作为产物：
  描述：

  对三氟甲氧基苯胺 、 1,4-萘醌 在 cerium(III) chloride heptahydrate 作用下， 以 乙醇 为溶剂， 以80 %的产率得到2-((4-(trifluoromethoxy)phenyl)amino)naphthalene-1,4-dione
  参考文献：
  名称：

  BENZOCARBAZOLE DERIVATIVES AS INHIBITORS OF DRP1

  摘要：

  The present application relates to compounds of Formula (I), Formula (II), and Formula (III) and to pharmaceutically acceptable salts and solvates of any of the foregoing, as well as pharmaceutical compositions and methods of using same to treat various diseases such as neurological and cardiac disorders.

  公开号：

  WO2023249965A1

文献信息

• [EN] COMPOSITIONS AND METHODS FOR TREATMENT OF PROSTATE CARCINOMA<br/>[FR] COMPOSITIONS ET MÉTHODES DE TRAITEMENT D'UN CARCINOME DE LA PROSTATE
  申请人：PELLFICURE PHARMACEUTICALS INC

  公开号：WO2016040896A1

  公开（公告）日：2016-03-17

  Disclosed herein are 1,4-naphthoquinone analogs, pharmaceutical compositions that include one or more of such 1,4-naphthoquinone analogs, and methods of treating and/or ameliorating diseases and/or conditions associated with a cancer, such as prostate cancer with such 1,4-naphthoquinone analogs. Also included are combination therapies wherein a 1,4-naphthoquinone analog disclosed herein, and a hormone therapy agent are provided to a subject suffering from a condition such as cancer.

  披露的是1,4-萘醌类似物，包括一个或多个这样的1,4-萘醌类似物的药物组合物，以及使用这些1,4-萘醌类似物治疗和/或改善与癌症相关的疾病和/或状况的方法，例如前列腺癌。还包括组合疗法，其中向患有癌症等状况的主体提供在本发明中披露的1,4-萘醌类似物和激素治疗剂。
• Compositions and methods for treatment of prostate carcinoma
  申请人：Pellficure Pharmaceuticals, Inc.

  公开号：US10093620B2

  公开（公告）日：2018-10-09

  Disclosed herein are 1,4-naphthoquinone analogs, pharmaceutical compositions that include one or more of such 1,4-naphthoquinone analogs, and methods of treating and/or ameliorating diseases and/or conditions associated with a cancer, such as prostate cancer with such 1,4-naphthoquinone analogs. Also included are combination therapies wherein a 1,4-naphthoquinone analog disclosed herein, and a hormone therapy agent are provided to a subject suffering from a condition such as cancer.

  本文公开了1,4-萘醌类似物、包括一种或多种此类1,4-萘醌类似物的药物组合物，以及用此类1,4-萘醌类似物治疗和/或改善与癌症（如前列腺癌）相关的疾病和/或病症的方法。还包括组合疗法，其中向患有癌症等疾病的受试者提供本文公开的 1,4-萘醌类似物和激素治疗剂。
• Electrochemical Regioselective C(<i>sp</i>²)–H Selenylation and Sulfenylation of Substituted 2-Amino-1,4-naphthoquinones
  作者：Pintu Karmakar、Indrajit Karmakar、Debopam Pal、Suravi Das、Goutam Brahmachari

  DOI：10.1021/acs.joc.2c02486

  日期：2023.1.20
• Visible‐Light‐Mediated Self‐Sensitized Oxidative and Regioselective C(sp ² )−H Selenylation and Sulfenylation of Substituted 2‐Amino‐1,4‐Naphthoquinones
  作者：Nayana Nayek、Goutam Brahmachari

  DOI：10.1002/ejoc.202201343

  日期：2023.1.10

  AbstractA photochemical method based on visible‐light (white LEDs/sunlight) irradiation has been developed for the regioselective and oxidative C(sp2)−H selenylation and sulfenylation of substituted 2‐amino‐1,4‐naphthoquinones under oxygen atmosphere. The photochemical process does not require any external photoredox catalysts. The other notable advantages of this protocol are metal‐free synthesis, visible light/sunlight as energy sources, good substrate scope, and moderate to good yields (41–91 %) with high regioselectivity.
• COMPOSITIONS AND METHODS FOR TREATMENT OF PROSTATE CARCINOMA
  申请人：Pellficure Pharmaceuticals, Inc.

  公开号：EP3191087A1

  公开（公告）日：2017-07-19